GLP-1 receptor agonists and acute diabetes complications in adults with type 1 diabetes
Authors:
- Hao DaiHDHao Dai
- Yao An LeeYLYao An Lee
- Rotana M. RadwanRRRotana M. Radwan
- Amy J. SheerASAmy J. Sheer
- Tamara S. HannonTHTamara S. Hannon
- Matthew R. HayesMHMatthew R. Hayes
- Ramon C. SunRSRamon C. Sun
- Jiang BianJiang Bian
- Jingchuan GuoJGJingchuan Guo
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK133465)
This publication has 46 references indexed in Scilit:
- GLP-1 Receptor Agonist and SGLT2 Inhibitor Prescribing in People With Type 1 DiabetesJAMA, 2024
- Validation of the Diagnostic Accuracy Levels of International Classification of Diseases, 10th Revision Codes for Diabetic Ketoacidosis: A Multicentre, Cross-sectional Study of AdultsCanadian Journal of Diabetes, 2024
- Heterogeneous treatment effects of metformin on risk of dementia in patients with type 2 diabetes: A longitudinal observational studyAlzheimer's & Dementia, 2023
- Diabetic ketoacidosisDisease-a-Month, 2022
- The association between GLP-1 receptor agonist and diabetic ketoacidosis in the FDA adverse event reporting systemNutrition, Metabolism and Cardiovascular Diseases, 2022
- Correction to: The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia, 2021
- Validation of data from electronic data warehouse in diabetic ketoacidosis: Caution is neededJournal of Diabetes and its Complications, 2018
- Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1Cell Metabolism, 2018
- Obesity PharmacotherapyMedical Clinics of North America, 2018
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009